Zealand University Hospital in Roskilde buys VibroSense Meter II - starts studies of chemotherapy and nerve damage
The Clinical Oncology Department at Zealand's University Hospital in Roskilde buys a VibroSense Meter II from VibroSense Dynamics in order to conduct two clinical studies. The signed agreement includes a purchase option to buy two additional instruments within three years. The clinical studies start on September 1, 2019 and will be made on patients with breast, ovarian and colorectal cancer. The studies aim to investigate how chemotherapy affects nerves in feet and hands.The research agreement involves a close collaboration between the Oncology Department at Zealand University Hospital and